The Driscoll Firm Seeks Over $1.75M in Lawsuit on Behalf of Injured Actos Diabetes Drug Patients

Share Article

Attorney John J. Driscoll of The Driscoll Firm, P.C., leads legal action on behalf of four plaintiffs against Actos maker Takeda Pharmaceuticals alleging negligence and deception by manufacturer.

Lawyer who has filed lawsuit involving Actos diabetes drug

John J. Driscoll

The complaint alleges that the makers of Actos and similar pioglitazone-containing medications knew the drug could cause serious bladder and urinary issues.

Nationally recognized drug injury attorney John J. Driscoll and The Driscoll Firm, P.C., have filed a new lawsuit against the makers of the diabetes drug commonly sold as Actos, alleging that the drug seriously injured four diabetics who used the medication.

The lawsuit (St. Clair County Circuit Court Case No. 13-L-15) alleges that the drug pioglitazone – marketed and sold as Actos, Actoplus Met, Actoplus Met XR and Duetact – caused “negative and detrimental effects” to the four plaintiffs’ bladders and urinary systems, including bladder cancer.

The lawsuit was filed in St. Clair County Circuit Court against Takeda Pharmaceuticals North America Inc., Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals LLC, Takeda San Diego Inc. and Takeda Pharmaceuticals International Inc.

The complaint alleges that the makers of Actos and similar pioglitazone-containing medications knew the drug could cause serious bladder and urinary issues. It accuses the defendants of negligence, deception in distributing a drug that could lead to life-threatening illnesses, failure to adequately monitor the long-term effects of the drug and failure to warn patients about its risks.

The plaintiffs ask to be awarded more than $1.75 million in damages in addition to court fees.

In a June 2011 Drug Safety Communication, the U.S. Food and Drug Administration (FDA) reported that the use of Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. Information about the risk was added to the “Warnings and Precautions” section of the label for pioglitazone-containing medicines such as Actos.

From January 2010 through October 2010, approximately 2.3 million patients filled prescriptions for a pioglitazone-containing product from outpatient retail pharmacies, the FDA said.

According to Driscoll, anyone who has experienced urinary tract problems, including bladder cancer, after using Actos or related medications should contact an experienced drug injury lawyer as soon as possible.

About The Driscoll Firm, P.C.
The Driscoll Firm, P.C., is dedicated to fighting for the rights of people and families injured by the wrongful acts of individuals and companies. The firm is currently investigating national injury claims involving product liability, defective drugs, dangerous medical devices, medical malpractice, car accidents, premises liability, spinal cord injuries, birth injuries, Cerebral Palsy, brain injuries, Erb's palsy and other circumstances that have caused serious injury or death. The Driscoll Firm, P.C., is based at 211 N. Broadway, 40th Floor, St. Louis, MO, 63102, and serves clients nationwide. To learn more, call (800) 305-9800 or use the firm’s online contact form. All initial consultations are free and confidential.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

John J. Driscoll

Mike Dayton
Visit website